NK cells specifically TCR-dressed to kill cancer cellsResearch in context
Background: Adoptive T-cell transfer of therapeutic TCR holds great promise to specifically kill cancer cells, but relies on modifying the patient's own T cells ex vivo before injection. The manufacturing of T cells in a tailor-made setting is a long and expensive process which could be resolve...
Main Authors: | Nadia Mensali, Pierre Dillard, Michael Hebeisen, Susanne Lorenz, Theodossis Theodossiou, Marit Renée Myhre, Anne Fåne, Gustav Gaudernack, Gunnar Kvalheim, June Helen Myklebust, Else Marit Inderberg, Sébastien Wälchli |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-02-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419300362 |
Similar Items
-
Sympathetic improvement of cancer vaccine efficacy
by: Else Marit Inderberg, et al.
Published: (2020-08-01) -
Determination of CAR T cell metabolism in an optimized protocol
by: Sandy Joaquina, et al.
Published: (2023-06-01) -
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
by: Sara M Mangsbo, et al.
Published: (2022-05-01) -
P611: CD37 AS A MOLECULAR TARGET FOR CAR-T CELLS AGAINST CHRONIC LYMPHOCYTIC LEUKEMIA
by: Aleksandra Kusowska, et al.
Published: (2023-08-01) -
Protocol for production of tonic CAR T cells with dasatinib
by: Léa Rosselle, et al.
Published: (2025-03-01)